NCT03378401View on ClinicalTrials.gov

Study to Assess the Inhibition of Plaque Formation in Subjects With a Gingival Index ≤1.5

PHASE3CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

January 11, 2018

Primary Completion Date

September 14, 2018

Study Completion Date

September 14, 2018

Conditions
Inhibition of Plaque Formation (by Gingivitis-Index ≤1.5)
Interventions
DRUG

Octenidinedihydrochlorid

Mouth rinsing of the oral cavity with Octenidinehydrochlorid vs.Placebo over a period of 5 days

OTHER

Placebo

Mouth rinsing of the oral cavity with Octenidinehydrochlorid vs.Placebo over a period of 5 days

Trial Locations (3)

1090

Universitätszahnklinik Wien, Fachbereich Zahnerhaltung und Parodontologie, Vienna

50931

Poliklinik für Zahnerhaltung und Parodontologie der Universitätsklinik Köln, Cologne

97070

Poliklinik für Zahnerhaltung und Parodontologie des Universitätsklinikums Würzburg, Würzburg

All Listed Sponsors
lead

Schülke & Mayr GmbH

INDUSTRY

NCT03378401 - Study to Assess the Inhibition of Plaque Formation in Subjects With a Gingival Index ≤1.5 | Biotech Hunter | Biotech Hunter